Evidence map›Paper›PMID 22323070›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2012

The legal risks of returning results of genomics research.

Ellen Wright Clayton, Amy L McGuire

Abstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. An Examination of the Ethical and Legal Limits in Implementing "Traceback Testing" for Deceased Patients.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Analogies in Genomics Policymaking: Debates and Drawbacks.American journal of human genetics · 2020
    Article
  12. Key Expert Stakeholder Perceptions of the Law of Genomics: Identified Problems and Potential Solutions.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Physicians' perspectives on receiving unsolicited genomic results.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. The Continuing Evolution of Ethical Standards for Genomic Sequencing in Clinical Care: Restoring Patient Choice.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2017
    Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ellen Wright ClaytonCenter for Biomedical Ethics and Society, Vanderbilt University, Nashville, Tennessee, USA.
Amy L McGuire

Funding

Vanderbilt Genome-Electronic Records ProjectU01HG004603 · NHGRI · VANDERBILT UNIVERSITY · PI RODEN, DAN M · 2007 to 2011
$7.3M
Managing Incidental Findings in Human Subjects ResearchR01HG003178 · NHGRI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI WOLF, SUSAN M. · 2005 to 2010
$1.5M
Returning Research Results of Pediatric Genomic Research to ParticipantsR21HG006612 · NHGRI · VANDERBILT UNIVERSITY · PI CLAYTON, ELLEN WRIGHT · 2011 to 2012
$389k
NHGRI NIH HHS 2R01 HG003178NHGRI NIH HHS 5U01 HG004603-03NHGRI NIH HHS R01 HG003178NHGRI NIH HHS R21 HG006612NHGRI NIH HHS U01 HG004603
6 · The paper itself

Abstract

Published guidelines suggest that research results and incidental findings should be offered to study participants under some circumstances. Although some have argued against the return of results in research, many cite an emerging consensus that there is an ethical obligation to return at least some results; the debate quickly turns to issues of mechanics (e.g., which results? who discloses? for how long does the obligation exist?). Although commentators are careful to distinguish this as an ethical rather than legal obligation, we worry that return of results may unjustifiably become standard of care based on this growing "consensus," which could quickly lead to a legal (negligence-based) duty to offer and return individualized genetic research results. We caution against this and argue in this essay that the debate to date has failed to give adequate weight to a number of fundamental ethical and policy issues that should undergird policy on return of research results in the first instance, many of which go to the fundamental differences between research and clinical care. We confine our comments to research using data from large biobanks, the topic of the guidelines proposed in this symposium issue.

Indexed as

Biomedical ResearchGenetics, MedicalGenomicsHumansResearcher-Subject RelationsResearch SubjectsRisk AssessmentTruth Disclosure

Identifiers

PMID22323070
PMCPMC3779603

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.